Special cash dividend (usd per share)
Common Stock, Dividends, Per Share, Cash Paid
Performance stock units issued and outstanding (unvested) under 2020 Equity Incentive Plan (in shares)
Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Performance Stock Units Available For Future Grant
Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Performance Stock Units Available For Future Grant
(Less): Accumulated amortization
Finite-Lived Intangible Assets, Accumulated Amortization
Agent fee (as a percent)
Sale of Stock, Sales Agent Fee, Percentage Of Gross Proceeds
Sale of Stock, Sales Agent Fee, Percentage Of Gross Proceeds
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND USE OF ESTIMATES
Significant Accounting Policies [Text Block]
Statistical Measurement [Domain]
Statistical Measurement [Domain]
Award Timing Predetermined
Award Timing Predetermined [Flag]
2025 (remaining six months)
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
Intangible assets, gross
Intangible Assets, Gross (Excluding Goodwill)
Entity File Number
Entity File Number
Additional Paid-In Capital
Additional Paid-in Capital [Member]
Tabular List, Table
Tabular List [Table Text Block]
Long-Lived Assets Held-for-Sale by Asset Type [Axis]
Long-Lived Asset, Held-for-Sale, Type [Axis]
Earnings Per Share, Basic [Abstract]
Earnings Per Share, Basic [Abstract]
Maximum milestone payments
Collaborative Arrangement, Maximum Milestone Payment
Collaborative Arrangement, Maximum Milestone Payment
Recently Issued or Effective Accounting Standards
New Accounting Pronouncements, Policy [Policy Text Block]
Proceeds from warrant cancellation payment
Proceeds From Cancellation Of Warrants
Proceeds From Cancellation Of Warrants
Tenant improvement allowance
Lessee, Tenant Improvement Allowance
Lessee, Tenant Improvement Allowance
Secured Overnight Financing Rate (SOFR)
Secured Overnight Financing Rate (SOFR) [Member]
Schedule of Financial Instruments Measured at Fair Value
Fair Value, by Balance Sheet Grouping [Table Text Block]
Unrealized losses
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax
Trading Arrangements, by Individual
Trading Arrangements, by Individual [Table]
Net loss per share - basic (usd per share)
Earnings Per Share, Basic
Adjustment to Compensation:
Adjustment to Compensation [Axis]
RELATED PARTY TRANSACTIONS
Related Party Transactions Disclosure [Text Block]
Named Executive Officers, Footnote
Named Executive Officers, Footnote [Text Block]
Commercial paper
Commercial Paper [Member]
Total shares of common stock reserved (in shares)
Common Stock, Capital Shares Reserved for Future Issuance
Other comprehensive income (loss)
Other Comprehensive Income (Loss), Net of Tax
Shares issued in connection with the employee stock purchase plan (in shares)
Stock Issued During Period, Shares, Employee Stock Purchase Plans
Square feet of office space
Area of Real Estate Property
2016 Plan
Equity Incentive Plan 2016 [Member]
Equity Incentive Plan 2016
Adjustment to Compensation, Amount
Adjustment to Compensation Amount
Concentration risk (as a percent)
Concentration Risk, Percentage
Consolidation
Consolidation, Policy [Policy Text Block]
Stock-based compensation
Share-Based Payment Arrangement, Noncash Expense
Stock Option Activity
Stock options, unexercised — vested and unvested
Share-Based Payment Arrangement, Option [Member]
Award Timing MNPI Disclosure
Award Timing MNPI Disclosure [Text Block]
Property, Plant and Equipment [Table]
Property, Plant and Equipment [Table]
Research and Development Costs
Research and Development Expense, Policy [Policy Text Block]
Antidilutive Securities [Axis]
Antidilutive Securities [Axis]
Special cash dividends paid
Dividends, Common Stock, Cash
Total stockholders’ equity
Beginning balance
Ending balance
Equity, Attributable to Parent
Debt Securities, Available-for-Sale [Table]
Debt Securities, Available-for-Sale [Table]
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Insider Trading Policies and Procedures [Line Items]
Total stock-based compensation
Share-Based Payment Arrangement, Expense
Schedule of Property and Equipment, Net
Property, Plant and Equipment [Table Text Block]
Common stock, authorized (in shares)
Common Stock, Shares Authorized
Issuance of common stock, net of issuance costs (in shares)
Stock Issued During Period, Shares, New Issues
Current assets:
Current assets:
Assets, Current [Abstract]
Forfeited (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Total liabilities and stockholders’ equity
Liabilities and Equity
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Number of Shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]
Concentration Risk Benchmark [Axis]
Concentration Risk Benchmark [Axis]
Concentration Risk
Concentration Risk, Credit Risk, Policy [Policy Text Block]
LIABILITIES AND STOCKHOLDERS' EQUITY
Liabilities and Equity [Abstract]
Cover [Abstract]
Cash and cash equivalents
Total cash equivalents
Cash and Cash Equivalents, Fair Value Disclosure
Maximum
Maximum [Member]
Exercisable (usd per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Initial useful life (in years)
Finite-Lived Intangible Asset, Useful Life
Raw materials
Inventory, Raw Materials, Noncurrent, Net of Reserves
Inventory, Raw Materials, Noncurrent, Net of Reserves
Accounting Policies [Abstract]
Total future amortization
Finite-Lived Intangible Assets, Net
Schedule of Future Contractual Lease Payments
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]
Concentration Risk Type [Domain]
Concentration Risk Type [Domain]
Non-cash lease expense
Operating Lease, Noncash Expense
Operating Lease, Noncash Expense
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Total Compensation Amount
Debt Instrument [Line Items]
Debt Instrument [Line Items]
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Schedule of Restricted Stock Unit Activity
Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]
Adjustment to Non-PEO NEO Compensation Footnote
Adjustment to Non-PEO NEO Compensation Footnote [Text Block]
Pay vs Performance Disclosure [Line Items]
Present value of operating lease payments
Total operating lease liability
Operating Lease, Liability
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Non-Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated [Flag]
Entity Shell Company
Entity Shell Company
Unrealized gains
Cash And Cash Equivalents, Accumulated Unrealized Gains, Before Tax
Cash And Cash Equivalents, Accumulated Unrealized Gains, Before Tax
Schedule of Long-term Debt Instruments [Table]
Schedule of Long-Term Debt Instruments [Table]
End of term charge
Line of Credit Facility, Periodic Payment, Interest
Statement of Stockholders' Equity [Abstract]
Schedule of Performance Stock Unit Activity
Share-Based Payment Arrangement, Performance Shares, Activity [Table Text Block]
Remaining lease term (years)
Lessee, Operating Lease, Remaining Lease Term
Accounts payable and other accrued liabilities
Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
Contractual milestone payment net sales
Collaborative Arrangement, Rights And Obligations, Contractual Milestone, Net Sales
Collaborative Arrangement, Rights And Obligations, Contractual Milestone, Net Sales
Statement of Cash Flows [Abstract]
Company Selected Measure Amount
Company Selected Measure Amount
Award Timing MNPI Considered
Award Timing MNPI Considered [Flag]
Other long-term liabilities
Increase (Decrease) in Other Noncurrent Liabilities
Comprehensive loss
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Security deposit
Security Deposit Liability
Name
Measure Name
Schedule of Stock-Based Compensation Expense
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Operating lease liability, current
Operating Lease, Liability, Current
Document Fiscal Period Focus
Document Fiscal Period Focus
Pharmakon Credit Facility, Tranche One
Pharmakon Credit Facility, Tranche One [Member]
Pharmakon Credit Facility, Tranche One
Award Timing Method
Award Timing Method [Text Block]
Schedule of Estimated Value of Cash, Cash Equivalents, Marketable Securities, and Equity Securities
Unrealized Gain (Loss) on Investments [Table Text Block]
Furniture and fixtures
Furniture and Fixtures [Member]
Award Type [Axis]
Award Type [Axis]
Long-term debt, net
Long-Term Debt
Common stock awards reserved for future issuance under 2020 and 2016 Equity Incentive Plans (in shares)
Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Stock Awards Available For Future Grant
Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Stock Awards Available For Future Grant
Legal Entity [Axis]
Legal Entity [Axis]
Milestone Determined by the Company
Milestone Determined by the Company [Member]
Milestone Determined by the Company
Number of leases
Lessee, Operating Lease, Number Of Lease Contracts
Lessee, Operating Lease, Number Of Lease Contracts
Total assets
Assets
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock-Based Compensation
Share-Based Payment Arrangement [Policy Text Block]
2026
Finite-Lived Intangible Asset, Expected Amortization, Year One
Trading Symbol
Trading Symbol
Vested (usd per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Restricted Cash
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]
Event-Based Development Milestone
Event-Based Development Milestone [Member]
Event-Based Development Milestone
Income Taxes
Income Tax, Policy [Policy Text Block]
Entity Address, City or Town
Entity Address, City or Town
Cash Flows From Operating Activities:
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]
Additional cash payment
Revenue, Remaining Performance Obligation, Additional Cash Payment
Revenue, Remaining Performance Obligation, Additional Cash Payment
Other reconciling items
Segment Reporting, Other Segment Item, Amount
Concentration Risk Type [Axis]
Concentration Risk Type [Axis]
Non-PEO NEO Average Compensation Actually Paid Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Income Statement Location [Domain]
Statement of Income Location, Balance [Domain]
Restricted Stock Unit Activity
Restricted Stock Units (RSUs) [Member]
Number of remaining additional tranches
Debt Instrument, Number Of Remaining Additional Tranches
Debt Instrument, Number Of Remaining Additional Tranches
Compensation Actually Paid vs. Other Measure
Compensation Actually Paid vs. Other Measure [Text Block]
2029
Finite-Lived Intangible Asset, Expected Amortization, Year Four
Entity Emerging Growth Company
Entity Emerging Growth Company
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Operating lease right-of-use asset obtained in exchange for operating lease liability
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
End of term charge, interest rate (as a percent)
Line of Credit Facility, Periodic Payment, Interest Rate
Line of Credit Facility, Periodic Payment, Interest Rate
Debt Securities, Available-for-Sale [Line Items]
Debt Securities, Available-for-Sale [Line Items]
Beginning balance (in shares)
Ending balance (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year
Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]
Level 2
Fair Value, Inputs, Level 2 [Member]
2023 ATM Prospectus
2023 ATM Prospectus [Member]
2023 ATM Prospectus
Insider Trading Policies and Procedures Not Adopted
Insider Trading Policies and Procedures Not Adopted [Text Block]
Common stock, outstanding (in shares)
Beginning balance (in shares)
Ending balance (in shares)
Common Stock, Shares, Outstanding
Plan Name [Axis]
Plan Name [Axis]
Follow-On Public Offering
Follow-On Public Offering [Member]
Follow-On Public Offering
Property and Equipment, Net
Property, Plant and Equipment, Policy [Policy Text Block]
PEO
PEO [Member]
Supplemental Disclosures From Noncash, Investing and Financing Activities:
Noncash Investing and Financing Items [Abstract]
Unvested
Share-Based Compensation Arrangement By Share-based Payment Award, Options, Nonvested, Aggregate Intrinsic Value
Share-Based Compensation Arrangement By Share-based Payment Award, Options, Nonvested, Aggregate Intrinsic Value
Unrealized loss (gain) from transactions denominated in a foreign currency
Unrealized Gain (Loss), Foreign Currency Transaction, before Tax
Changes in operating assets and liabilities:
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]
Exercise of vested stock options
Stock Issued During Period, Value, Stock Options Exercised
Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year
Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]
Schedule of Expected Future Amortization Expense
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]
Accumulated Deficit
Retained Earnings [Member]
Upfront payment received
Collaborative Arrangement, Rights And Obligations, Upfront Payment
Collaborative Arrangement, Rights And Obligations, Upfront Payment
Effective interest rate (as a percent)
Debt Instrument, Interest Rate, Effective Percentage
Number of Shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Pre-funded warrants reserved for future issuance (in shares)
Class of Warrant Or Right, Reserved for Future Issuance
Class of Warrant Or Right, Reserved for Future Issuance
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Restatement Determination Date
Restatement Determination Date
Share-Based Payment Arrangement [Abstract]
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Income Statement [Abstract]
Basis spread on variable rate (as a percent)
Debt Instrument, Basis Spread on Variable Rate
Pharmakon Credit Facility
Pharmakon Credit Facility [Member]
Pharmakon Credit Facility
Sale of Stock [Domain]
Sale of Stock [Domain]
Preferred stock, issued (in shares)
Preferred Stock, Shares Issued
Intangible assets, net
Intangible assets, net
Intangible Assets, Net (Excluding Goodwill)
Pension Adjustments Service Cost
Pension Adjustments Service Cost [Member]
Product and Service [Domain]
Product and Service [Domain]
Marketable securities:
Debt Securities, Available-for-Sale [Abstract]
Fair Value Hierarchy and NAV [Axis]
Fair Value Hierarchy and NAV [Axis]
Customer Concentration Risk
Customer Concentration Risk [Member]
Interest expense for long-term debt
Interest Expense, Debt, Excluding Amortization
Property and equipment, at cost
Property, Plant and Equipment, Gross
Prime Rate
Prime Rate [Member]
Purchases of long-term investments
Payments to Acquire Long-Term Investments
Restatement does not require Recovery
Restatement Does Not Require Recovery [Text Block]
Future cash payments
Collaborative Arrangement, Future Cash Payments
Collaborative Arrangement, Future Cash Payments
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Compensation Actually Paid vs. Company Selected Measure
Compensation Actually Paid vs. Company Selected Measure [Text Block]
Proceeds from exercise of stock options
Proceeds from Stock Options Exercised
City Area Code
City Area Code
Award Timing, How MNPI Considered
Award Timing, How MNPI Considered [Text Block]
All Trading Arrangements
All Trading Arrangements [Member]
Equity Awards Adjustments, Footnote
Equity Awards Adjustments, Footnote [Text Block]
Total Shareholder Return Vs Peer Group
Total Shareholder Return Vs Peer Group [Text Block]
Outstanding, beginning balance (in shares)
Outstanding, ending balance (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Abstract]
Cash Flows From Investing Activities:
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]
Unrecognized compensation expense
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Pay vs Performance Disclosure
Pay vs Performance Disclosure [Table]
Net cash used in operating activities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Unvested (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares
Commercial Sales Milestone Payments
Commercial Sales Milestone Payments [Member]
Commercial Sales Milestone Payments
Unvested (in years)
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Nonvested, Weighted Average Remaining Contractual Term
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Nonvested, Weighted Average Remaining Contractual Term
Long-term investments
Long-Term Investments
Related Party Transactions [Abstract]
Useful lives of assets (in years)
Property, Plant and Equipment, Useful Life
Preferred stock, par value (usd per share)
Preferred Stock, Par or Stated Value Per Share
Schedule of Valuation Assumptions of Stock Options
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Total lease expense
Lease, Cost
Selling, general and administrative
Selling, General and Administrative Expenses [Member]
Cost of sales
Cost of Sales [Member]
Equity Valuation Assumption Difference, Footnote
Equity Valuation Assumption Difference, Footnote [Text Block]
Schedule of Components of Lease Cost
Lease, Cost [Table Text Block]
PEO Total Compensation Amount
PEO Total Compensation Amount
Long-term Debt, Type [Axis]
Long-Term Debt, Type [Axis]
Depreciation
Depreciation
Money market funds
Money Market Funds [Member]
2025 (remaining six months)
Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
Equity Components [Axis]
Equity Components [Axis]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment [Line Items]
Tranches with minimum net sales milestones
Debt Instrument, Number Of Tranches With Milestone Requirements
Debt Instrument, Number Of Tranches With Milestone Requirements
Non-Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted [Flag]
Product sales, net
Product [Member]
Number of reportable segments
Number of Reportable Segments
Amortized cost
Amortized cost
Debt Securities, Available-for-Sale, Amortized Cost
Other Performance Measure, Amount
Other Performance Measure, Amount
Weighted- Average Exercise Price/Share ($)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Payments of debt issuance costs
Payments of Debt Issuance Costs
Entity Address, State or Province
Entity Address, State or Province
Marketable Securities and Long-Term Investments
Marketable Securities, Policy [Policy Text Block]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Antidilutive Security, Excluded EPS Calculation [Table]
Fair Value Measurements
Fair Value Measurement, Policy [Policy Text Block]
Upon Execution of the Novation Agreement
Upon Execution of the Novation Agreement [Member]
Upon Execution of the Novation Agreement
Total current liabilities
Liabilities, Current
Underwriters' option
Over-Allotment Option [Member]
Upon Execution of Warrant Termination Agreement
Upon Execution of Warrant Termination Agreement [Member]
Upon Execution of Warrant Termination Agreement
Issuance of common stock upon the vesting of restricted stock units (in shares)
Stock Issued During Period, Shares, Restricted Stock Award, Gross
Individual:
Individual [Axis]
LianBio
LianBio [Member]
LianBio
Other receivables
Increase (Decrease) in Other Receivables
Research and development
Research and Development Expense [Member]
Entity [Domain]
Entity [Domain]
Offering costs included within accounts payable and other accrued liabilities
Deferred Offering Costs Incurred But Not Yet Paid, Included In Accounts Payable And Accrued Liabilities
Deferred Offering Costs Incurred But Not Yet Paid, Included In Accounts Payable And Accrued Liabilities
Net cash used in investing activities
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Restricted stock units issued and outstanding (unvested) under 2020 Equity Incentive Plan (in shares)
Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Restricted Stock Units Available For Future Grant
Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Restricted Stock Units Available For Future Grant
Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table
Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]
Interest expense paid in cash
Interest Paid, Excluding Capitalized Interest, Operating Activity
Document Fiscal Year Focus
Document Fiscal Year Focus
Basis of Presentation
Basis of Accounting, Policy [Policy Text Block]
Operating lease right-of-use assets
Operating Lease, Right-of-Use Asset
Forgone Recovery, Explanation of Impracticability
Forgone Recovery, Explanation of Impracticability [Text Block]
Entity Interactive Data Current
Entity Interactive Data Current
Operating lease expense
Operating Lease, Cost
Plan Name [Domain]
Plan Name [Domain]
Unrecognized compensation expense, weighted average period of recognition (in years)
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Exercise of vested stock options (in shares)
Exercised (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value
SEGMENT REPORTING
Segment Reporting Disclosure [Text Block]
Remaining useful life (in years)
Finite-Lived Intangible Assets, Remaining Amortization Period
U.S. Treasury securities
US Treasury Securities [Member]
Number of securities with contractual maturity between one and three years
Debt Securities, Available-for-Sale, Contractual Maturities Greater Than Twelve Months, Number of Securities
Debt Securities, Available-for-Sale, Contractual Maturities Greater Than Twelve Months, Number of Securities
Long-Lived Tangible Asset [Axis]
Long-Lived Tangible Asset [Axis]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Total Shareholder Return [Text Block]
Interest rate floor (as a percent)
Debt Instrument, Floor Interest Rate
Debt Instrument, Floor Interest Rate
Leases
Lessee, Leases [Policy Text Block]
Amortization of intangible assets
Amortization expense
Amortization of Intangible Assets
Selling, general and administrative
General and administrative
Selling, General and Administrative Expense
Depreciation and amortization expense
Depreciation, Depletion and Amortization
Other assets
Other Assets, Noncurrent
Customer [Domain]
Customer [Domain]
Entity Central Index Key
Entity Central Index Key
PEO Name
PEO Name
Total revenues
Revenues
Stock issued, net proceeds
Sale of Stock, Consideration Received on Transaction
Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year
Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Outstanding Aggregate Erroneous Compensation Amount
Outstanding Aggregate Erroneous Compensation Amount
Accounts Receivable, Net
Accounts Receivable [Policy Text Block]
Arrangement Duration
Trading Arrangement Duration
Schedule of Segment Reporting Information, by Segment [Table]
Schedule of Segment Reporting Information, by Segment [Table]
Grandpharma
Grandpharma [Member]
Grandpharma
Segments [Axis]
Segments [Axis]
Exercise price per warrant (usd per share)
Class of Warrant or Right, Exercise Price of Warrants or Rights
Work in progress
Inventory, Work in Process, Net of Reserves
Exercise Price
Award Exercise Price
Entity Filer Category
Entity Filer Category
Local Phone Number
Local Phone Number
Additional 402(v) Disclosure
Additional 402(v) Disclosure [Text Block]
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Unrecognized compensation expense
Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount
STOCK-BASED COMPENSATION
Share-Based Payment Arrangement [Text Block]
ASSETS
Assets:
Assets [Abstract]
Long-term debt, net
Long-Term Debt, Excluding Current Maturities
Inventory, non-current
Inventory, non-current
Inventory, Noncurrent
Underlying Security Market Price Change
Underlying Security Market Price Change, Percent
2028
Finite-Lived Intangible Asset, Expected Amortization, Year Three
Debt Instrument [Axis]
Debt Instrument [Axis]
Forfeited (usd per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
FAIR VALUE MEASUREMENTS
Fair Value Disclosures [Text Block]
Loss on debt extinguishment
Loss on debt extinguishment
Loss on debt extinguishment
Gain (Loss) on Extinguishment of Debt
Stockholders’ equity:
Equity, Attributable to Parent [Abstract]
Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year
Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]
Development and Regulatory Milestone
Development And Regulatory Milestone [Member]
Development And Regulatory Milestone
Entity Address, Address Line One
Entity Address, Address Line One
Research and development
Research and Development Expense
Accumulated Other Comprehensive Income (Loss)
AOCI Attributable to Parent [Member]
Operating lease liability, noncurrent
Operating Lease, Liability, Noncurrent
Commercial and sales milestones
Commercial And Sales Milestones [Member]
Commercial And Sales Milestones
Royalty expense
Royalty Expense
Schedule of Total Shares Reserved For Future Issuance
Schedule of Stock by Class [Table Text Block]
Fair Value as of Grant Date
Award Grant Date Fair Value
Amortized cost
Equity Securities, FV-NI, Cost
Entity Registrant Name
Entity Registrant Name
Other non-current assets
Increase (Decrease) in Other Noncurrent Assets
Stock Price or TSR Estimation Method
Stock Price or TSR Estimation Method [Text Block]
Weighted average volatility
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate
Granted (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period
Issuance of pre-funded warrants, net of issuance costs
Class of Warrant or Right, Payments of Issuance Costs
Class of Warrant or Right, Payments of Issuance Costs
Intangible Assets, Milestone Payment
Intangible Assets, Milestone Payment [Member]
Intangible Assets, Milestone Payment
Total operating expenses
Costs and Expenses
Forfeited (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Weighted- Average Remaining Contractual Term (Years)
Share-based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term [Abstract]
Share-based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Document Quarterly Report
Document Quarterly Report
Aggregate Intrinsic Value
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Aggregate Intrinsic Value [Abstract]
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Aggregate Intrinsic Value
Long-Lived Assets Held-for-Sale, Name [Domain]
Long-Lived Assets Held-for-Sale, Name [Domain]
Total assets measured at fair value
Assets, Fair Value Disclosure
Changed Peer Group, Footnote
Changed Peer Group, Footnote [Text Block]
Counterparty Name [Domain]
Counterparty Name [Domain]
Common stock votes
Common Stock, Number Of Votes
Common Stock, Number Of Votes
Non-current assets:
Inventory, Noncurrent [Abstract]
Net amortization/accretion of marketable securities
Accretion (Amortization) of Discounts and Premiums, Investments
Adjustment To PEO Compensation, Footnote
Adjustment To PEO Compensation, Footnote [Text Block]
Preferred stock purchased
Payments to Acquire Equity Securities, FV-NI
Outstanding (in years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Schedule of Principal Balance of the 2024 Credit Facility
Schedule of Debt [Table Text Block]
Schedule of Accounts Payable and Other Accrued Liabilities
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]
Manufacturing equipment
Machinery and Equipment [Member]
Granted (usd per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Title
Trading Arrangement, Individual Title
Peer Group Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Stock options issued and outstanding (unvested and vested) under 2020 and 2016 Equity Incentive Plans (in shares)
Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Stock Options Issued And Outstanding
Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Stock Options Issued And Outstanding
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Restatement Determination Date:
Restatement Determination Date [Axis]
Non-PEO NEO
Non-PEO NEO [Member]
Outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Accounts Receivable
Accounts Receivable [Member]
Shares issued in connection with the employee stock purchase plan
Stock Issued During Period, Value, Employee Stock Purchase Plan
Total interest expense
Interest Expense, Debt
Interest income
Interest Income, Other
Accrued royalty payable
Accrued Royalty Payable, Current
Accrued Royalty Payable, Current
Sale of Stock [Axis]
Sale of Stock [Axis]
Unrealized gains
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax
Name
Trading Arrangement, Individual Name
Award Type [Domain]
Award Type [Domain]
Payments for debt extinguishment
Payment for Debt Extinguishment or Debt Prepayment Cost
Two Customers
Two Customers [Member]
Two Customers
Equity Awards Adjustments
Equity Awards Adjustments [Member]
Leasehold improvements
Leasehold Improvements [Member]
Pension Benefits Adjustments, Footnote
Pension Benefits Adjustments, Footnote [Text Block]
Compensation Amount
Outstanding Recovery Compensation Amount
Debt Instrument, Name [Domain]
Debt Instrument, Name [Domain]
Expected dividend yield (as a percent)
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Recovery of Erroneously Awarded Compensation Disclosure [Line Items]
Accrued payroll and benefits
Increase (Decrease) in Employee Related Liabilities
Price per warrant (usd per share)
Class of Warrant or Right, Sale Price
Class of Warrant or Right, Sale Price
MNPI Disclosure Timed for Compensation Value
MNPI Disclosure Timed for Compensation Value [Flag]
Name
Awards Close in Time to MNPI Disclosures, Individual Name
Unvested (usd per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price
Outstanding, beginning balance (usd per share)
Outstanding, ending balance (usd per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Restricted cash, non-current
Restricted Cash, Noncurrent
Aggregate Erroneous Compensation Not Yet Determined
Aggregate Erroneous Compensation Not Yet Determined [Text Block]
Employee Stock Purchase Plan
Employee Stock [Member]
Revenues:
Revenues [Abstract]
Recognition of stock-based compensation expense
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
Accumulated other comprehensive income (loss)
Accumulated Other Comprehensive Income (Loss), Net of Tax
Selling and marketing
Selling and Marketing Expense
Net proceeds
Proceeds from (Repayments of) Debt
Financial Instruments [Domain]
Financial Instruments [Domain]
Unrealized gain (loss) on marketable securities and cash equivalents
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax
Thereafter
Finite-Lived Intangible Asset, Expected Amortization, after Year Four
Finite-Lived Intangible Asset, Expected Amortization, after Year Four
Segments [Domain]
Segments [Domain]
Income Statement Location [Axis]
Statement of Income Location, Balance [Axis]
Performance Stock Unit Activity
Performance Shares [Member]
Aggregate Pension Adjustments Service Cost
Aggregate Pension Adjustments Service Cost [Member]
Fair Value Hierarchy and NAV [Domain]
Fair Value Hierarchy and NAV [Domain]
Inventory
Increase (Decrease) in Inventories
Inventory
Inventory
Inventory, Net
Amortization of debt-related costs
Amortization of Debt Issuance Costs and Discounts
Minimum
Minimum [Member]
Pre-funded warrants to purchase common stock (in shares)
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
(Less): Accumulated depreciation
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Net Loss per Share
Earnings Per Share, Policy [Policy Text Block]
Company Selected Measure Name
Company Selected Measure Name
Government-related debt securities
US Government Debt Securities [Member]
Revenue Recognition
Revenue [Policy Text Block]
Cost of Sales
Cost of Goods and Service [Policy Text Block]
Purchases of marketable securities
Payments to Acquire Debt Securities, Available-for-Sale
Schedule of Intangible Assets, Net
Finite-Lived Intangible Assets Amortization Expense [Table Text Block]
CREDIT FACILITY AGREEMENTS
Debt Disclosure [Text Block]
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding
Preferred Stock, Value, Issued
Aggregate Available
Trading Arrangement, Securities Aggregate Available Amount
Cash paid for our current lease
Operating Lease, Payments
Proceeds from sale of common stock under employee stock purchase plan
Proceeds from Stock Plans
Stock Appreciation Rights (SARs)
Stock Appreciation Rights (SARs) [Member]
All Executive Categories
All Executive Categories [Member]
Sales-based Milestones
Sales-Based Milestones [Member]
Sales-based Milestones
Impairments of intangible assets
Impairment of Intangible Assets (Excluding Goodwill)
Finished goods
Inventory, Finished Goods, Net of Reserves
Common stock, $0.0001 par value; 200,000,000 shares authorized; 42,210,972 shares issued and outstanding at June 30, 2025 (unaudited); 38,349,826 shares issued and outstanding at December 31, 2024
Common Stock, Value, Issued
COMMITMENTS & CONTINGENCIES
Commitments and Contingencies Disclosure [Text Block]
Weighted-average shares outstanding - diluted (in shares)
Weighted Average Number of Shares Outstanding, Diluted
Four Customers
Four Customers [Member]
Four Customers
Commitments and contingencies (Note 8)
Commitments and Contingencies
Non-GAAP Measure Description
Non-GAAP Measure Description [Text Block]
Pharmakon Credit Facility, Tranche Two
Pharmakon Credit Facility, Tranche Two [Member]
Pharmakon Credit Facility, Tranche Two
Entity Smaller Reporting Company
Entity Small Business
Issuance of common stock, net of issuance costs
Payments of Stock Issuance Costs
Preferred stock, outstanding (in shares)
Preferred Stock, Shares Outstanding
Document Transition Report
Document Transition Report
Underlying Securities
Award Underlying Securities Amount
Reportable Segment
Reportable Segment [Member]
Reportable Segment
Laboratory equipment
Other Machinery and Equipment [Member]
Equity Component [Domain]
Equity Component [Domain]
Document Period End Date
Document Period End Date
PEO Actually Paid Compensation Amount
PEO Actually Paid Compensation Amount
Restricted stock units — unvested
Share-Based Payment Arrangement, Equity Instruments Other Than Options, Restricted Stock Units, Unvested [Member]
Share-Based Payment Arrangement, Equity Instruments Other Than Options, Restricted Stock Units, Unvested
BALANCE SHEET ACCOUNT DETAIL
Supplemental Balance Sheet Disclosures [Text Block]
Draw on credit facility
Proceeds from Lines of Credit
Awards Close in Time to MNPI Disclosures, Table
Awards Close in Time to MNPI Disclosures [Table Text Block]
License fees and collaboration revenue
License And Collaboration [Member]
License And Collaboration
Scenario [Axis]
Scenario [Axis]
Exercisable (in years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Accretion of end of term charge
Amortization of Debt Discount (Premium)
Document Type
Document Type
Level 3
Fair Value, Inputs, Level 3 [Member]
NET LOSS PER SHARE
Earnings Per Share [Text Block]
Name
Outstanding Recovery, Individual Name
Additional paid-in capital
Additional Paid in Capital
Accounts payable and other accrued liabilities
Accounts payable and other accrued liabilities
Accounts Payable and Other Accrued Liabilities, Current
Office equipment
Office Equipment [Member]
Product and Service [Axis]
Product and Service [Axis]
Proceeds from issuance of common stock, net of paid issuance costs
Proceeds from Issuance of Common Stock
Available-for-sale Debt Securities, Contractual Maturity Less Than 12 Months
Available-for-sale Debt Securities, Contractual Maturity Greater Than 12 Months [Member]
Available-for-sale Debt Securities, Contractual Maturity Greater Than 12 Months
Revenue recognized
Revenue from Contract with Customer, Excluding Assessed Tax
Variable lease expense
Variable Lease, Cost
Clinical milestones
Clinical Milestones [Member]
Clinical Milestones
Service condition period for full vesting (in years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period
License agreement
Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]
All Individuals
All Individuals [Member]
Long-term Debt, Type [Domain]
Long-Term Debt, Type [Domain]
Fair Value Disclosures [Abstract]
Purchases of property and equipment
Payments to Acquire Property, Plant, and Equipment
Name
Forgone Recovery, Individual Name
Total current assets
Assets, Current
Statistical Measurement [Axis]
Statistical Measurement [Axis]
Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested
Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]
Other receivables
Other Receivables, Net, Current
Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Amount
Fair market value of common stock (as a percent)
Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent
Rent abatement
Incentive from Lessor
Peer Group Issuers, Footnote
Peer Group Issuers, Footnote [Text Block]
Three Customers
Three Customers [Member]
Three Customers
Marketable securities
Marketable Securities, Current
Erroneous Compensation Analysis
Erroneous Compensation Analysis [Text Block]
Contractual maturity (in years)
Debt Securities, Available-for-Sale, Term
Schedule of Operating Financial Results of Therapeutics Segment
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
Current liabilities:
Liabilities, Current [Abstract]
Lessee, Lease, Description [Line Items]
Lessee, Lease, Description [Line Items]
Rule 10b5-1 Arrangement Terminated
Rule 10b5-1 Arrangement Terminated [Flag]
Level 1
Fair Value, Inputs, Level 1 [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Net loss per share - diluted (usd per share)
Earnings Per Share, Diluted
Forecast
Forecast [Member]
Erroneously Awarded Compensation Recovery
Erroneously Awarded Compensation Recovery [Table]
Accounts receivable, net
Accounts Receivable, after Allowance for Credit Loss, Current
Concentration Risk Benchmark [Domain]
Concentration Risk Benchmark [Domain]
Title of 12(b) Security
Title of 12(b) Security
Lessee, Lease, Description [Table]
Lessee, Lease, Description [Table]
Accrued product sales deductions
Accrued Sales Commission, Current
Stock issued (in shares)
Sale of Stock, Number of Shares Issued in Transaction
Earnings Per Share [Abstract]
Earnings Per Share [Abstract]
Common stock awards reserved for future issuance under the 2020 Employee Stock Purchase Plan (in shares)
Common Stock, Capital Shares Reserved for Future Issuance, Employee Stock Purchase Plan
Common Stock, Capital Shares Reserved for Future Issuance, Employee Stock Purchase Plan
DESCRIPTION OF BUSINESS AND PRESENTATION OF FINANCIAL STATEMENTS
Business Description and Basis of Presentation [Text Block]
Total other income (expense), net
Nonoperating Income (Expense)
Prepaid expenses
Increase (Decrease) in Prepaid Expense
Elanco
Elanco [Member]
Elanco
Schedule of Outstanding Potentially Dilutive Securities
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Schedule of Interest Expense
Interest Income and Interest Expense Disclosure [Table Text Block]
Comprehensive Loss
Comprehensive Income, Policy [Policy Text Block]
Security deposit, decrease limit
Security Deposit Liability, Decrease Limit
Security Deposit Liability, Decrease Limit
Potential additional tranches
Debt Instrument, Number Of Potential Additional Tranches
Debt Instrument, Number Of Potential Additional Tranches
(Less): Imputed interest
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Authorized consideration
Sale of Stock, Consideration Amount Authorized
Sale of Stock, Consideration Amount Authorized
Exercised (usd per share)
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
2027
Finite-Lived Intangible Asset, Expected Amortization, Year Two
Award Timing Disclosures [Line Items]
Schedule of Inventory
Schedule of Inventory, Current [Table Text Block]
Principal outstanding
Long-term debt, gross
Long-Term Debt, Gross
Granted (usd per share)
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Accrued payroll and benefits
Employee-related Liabilities, Current
Total future lease payments, undiscounted
Lessee, Operating Lease, Liability, to be Paid
Upfront payment received
Upfront Payment
Upfront Payment
Net loss
Net loss
Net loss
Net Income (Loss) Attributable to Parent
Expiration Date
Trading Arrangement Expiration Date
Milestone payments to be achieved
Revenue, Remaining Performance Obligation, Variable Consideration, Amount
Revenue, Remaining Performance Obligation, Variable Consideration, Amount
Property and equipment, net
Property and equipment, net
Property, Plant and Equipment, Net
Segment Reporting Information [Line Items]
Segment Reporting Information [Line Items]
Preferred stock, authorized (in shares)
Preferred Stock, Shares Authorized
Adoption Date
Trading Arrangement Adoption Date
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Net Income [Text Block]
Accounts receivable, net
Increase (Decrease) in Accounts Receivable
Annual increase in rent (as a percent)
Lessee, Operating Lease, Annual Rent Increase, Percent
Lessee, Operating Lease, Annual Rent Increase, Percent
Inventory
Inventory, Policy [Policy Text Block]
Entity Current Reporting Status
Entity Current Reporting Status
Lease term (in years)
Lessee, Operating Lease, Term of Contract
Customer [Axis]
Customer [Axis]
Selling, General and Administrative
Selling, General and Administrative Expenses, Policy [Policy Text Block]
Awards Close in Time to MNPI Disclosures
Awards Close in Time to MNPI Disclosures [Table]
Loss from operations before other income (expense)
Operating Income (Loss)
Line of Credit
Line of Credit [Member]
2023 Shelf Registration Statement
2023 Shelf Registration Statement [Member]
2023 Shelf Registration Statement
Accumulated deficit
Retained Earnings (Accumulated Deficit)
Change in fair value of equity warrants issued by licensee
Embedded Derivative, Gain (Loss) on Embedded Derivative, Net
Financial Instrument [Axis]
Financial Instrument [Axis]
Statement of Financial Position [Abstract]
Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested
Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]
Executive Category:
Executive Category [Axis]
Number of available-for-sale debt securities in gross unrealized loss position for less than one year
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions
Proceeds from long-term debt
Proceeds from Issuance of Long-Term Debt
Current Fiscal Year End Date
Current Fiscal Year End Date
Expected term (in years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term
Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table
Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]
Pharmakon Credit Facility, Tranche Three
Pharmakon Credit Facility, Tranche Three [Member]
Pharmakon Credit Facility, Tranche Three
Weighted Average Value per Share
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Other income (expense), net
Other Nonoperating Income (Expense)
Statement [Table]
Statement [Table]
Adjustments to reconcile net loss to net cash used in operating activities:
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]
OUT-LICENSE AGREEMENTS
Collaborative Arrangement Disclosure [Text Block]
Cash Flows From Financing Activities:
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]
Weighted-average grant-date fair value per stock option (usd per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Equity Awards Adjustments, Excluding Value Reported in Compensation Table
Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]
Revenue Benchmark
Revenue Benchmark [Member]
Issuance of pre-funded warrants, net of issuance costs
Adjustments to Additional Paid in Capital, Warrant Issued
Variable Rate [Domain]
Variable Rate [Domain]
Upfront payment
Contract with Customer, Liability
Proceeds from maturities of marketable securities
Proceeds from Sale and Maturity of Marketable Securities
One Customer
One Customer [Member]
One Customer
Cash equivalents:
Cash and Cash Equivalents [Abstract]
Total potentially dilutive securities were excluded from diluted net loss per share (in shares)
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
All Adjustments to Compensation
All Adjustments to Compensation [Member]
Fair Value, by Balance Sheet Grouping [Table]
Fair Value, by Balance Sheet Grouping [Table]
Amendment Flag
Amendment Flag
Original issue price (usd per share)
Sale of Stock, Price Per Share
Debt issuance costs
Debt Issuance Costs, Line of Credit Arrangements, Net
Termination Date
Trading Arrangement Termination Date
Net cash provided by financing activities
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Adopted [Flag]
Measure:
Measure [Axis]
Cash and Cash Equivalents
Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block]
Discount rate
Operating Lease, Weighted Average Discount Rate, Percent
Schedule of Stock Option Activity
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Long-Lived Tangible Asset [Domain]
Long-Lived Tangible Asset [Domain]
Weighted-average shares outstanding, basic (in shares)
Weighted-average shares outstanding - basic (in shares)
Weighted Average Number of Shares Outstanding, Basic
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Debt securities, available for sale and cash and cash equivalents
Debt Securities, Available-For-Sale And Cash And Cash Equivalents
Debt Securities, Available-For-Sale And Cash And Cash Equivalents
Cost of sales
Cost of Product and Service Sold
Schedule of Computation of Basic and Diluted Net Loss Per Share
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Exercisable (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Subsequent Events [Abstract]
Segment Reporting [Abstract]
Pay vs Performance Disclosure, Table
Pay vs Performance [Table Text Block]
Base rent expense
Operating Lease, Expense
Debt Disclosure [Abstract]
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Amortization of debt issuance costs
Amortization of Debt Issuance Costs
Weighted average risk-free interest rate
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Other income (expense):
Nonoperating Income (Expense) [Abstract]
Entity Tax Identification Number
Entity Tax Identification Number
Scenario [Domain]
Scenario [Domain]
Other segment disclosures:
Segment Reporting Information, Additional Information [Abstract]
Beginning balance (usd per share)
Ending balance (usd per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Trade accounts payable and other
Accounts Payable, Trade, Current
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Expense of Enforcement, Amount
Number of employment arrangements with executive officers
Number Of Employment Arrangements With Executive Officers
Number Of Employment Arrangements With Executive Officers
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common stock, par value (usd per share)
Common Stock, Par or Stated Value Per Share
Common stock, issued (in shares)
Common Stock, Shares, Issued
Realized loss on equity investments
Equity Securities, FV-NI, Realized Gain (Loss)
Granted (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Use of Estimates
Use of Estimates, Policy [Policy Text Block]
Total inventory
Inventory, Current And Noncurrent, Net
Inventory, Current And Noncurrent, Net
Interest expense
Interest Expense, Nonoperating
Trading Arrangement:
Trading Arrangement [Axis]
Total Shareholder Return Amount
Total Shareholder Return Amount
SUBSEQUENT EVENT
Subsequent Events [Text Block]
Insider Trading Arrangements [Line Items]
Proceeds from issuance of pre-funded warrants, net of paid issuance costs
Proceeds from Issuance of Warrants
Security Exchange Name
Security Exchange Name
Forfeited (usd per share)
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Accumulated amortization of debt issuance costs
Accumulated Amortization, Debt Issuance Costs
Total liabilities
Liabilities
Antidilutive Securities, Name [Domain]
Antidilutive Securities, Name [Domain]
Additions of property and equipment included within accounts payable and other accrued liabilities
Capital Expenditures Incurred but Not yet Paid
Credit facility, aggregate principal amount
Line of Credit Facility, Maximum Borrowing Capacity
Pension Adjustments Prior Service Cost
Pension Adjustments Prior Service Cost [Member]
Thereafter
Lessee, Operating Lease, Liability, to be Paid, After Current Fiscal Year
Lessee, Operating Lease, Liability, to be Paid, After Current Fiscal Year
Operating expenses:
Operating Expenses [Abstract]
Prepaid expenses
Prepaid Expense, Current
Material Terms of Trading Arrangement
Material Terms of Trading Arrangement [Text Block]
Issuance of common stock, net of issuance costs
Stock Issued During Period, Value, New Issues
Statement [Line Items]
Statement [Line Items]
Variable Rate [Axis]
Variable Rate [Axis]
Rule 10b5-1 Arrangement Adopted
Rule 10b5-1 Arrangement Adopted [Flag]
Amortized cost
Cash and Cash Equivalent
Counterparty Name [Axis]
Counterparty Name [Axis]
Underwriter purchase option (in days)
Sale of Stock, Underwriter Purchase Option, Term
Sale of Stock, Underwriter Purchase Option, Term
Common Stock
Common Stock [Member]
Vested (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Total marketable securities
Corporate debt securities
Debt Securities, Available-for-Sale
Intangible Assets, Net
Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Non-NEOs
Non-NEOs [Member]
Corporate debt securities
Corporate Debt Securities [Member]
Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation